SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-112092
Filing Date
2017-04-06
Accepted
2017-04-05 18:38:02
Documents
1
Group Members
ABG II-SO LTDABG II-USL1 LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO.3 d364164dsc13ga.htm SC 13G/A 75091
  Complete submission text file 0001193125-17-112092.txt   77071
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Subject) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54715 | Film No.: 17743870
SIC: 2834 Pharmaceutical Preparations

Mailing Address ABG MGMT LTD., UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG F4 00000
Business Address ABG MGMT LTD., UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG F4 00000 (852) 3121-9699
Ally Bridge Group Capital Partners II, L.P. (Filed by) CIK: 0001609313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13G/A